Venus Remedies Limited (NSE:VENUSREM)

Market Cap	6.08B
Revenue (ttm)	6.48B
Net Income (ttm)	453.20M
Shares Out	n/a
EPS (ttm)	33.90
PE Ratio	13.42
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	39,284
Average Volume	66,306
Open	459.00
Previous Close	458.95
Day's Range	442.65 - 475.50
52-Week Range	270.25 - 476.90
Beta	0.62
RSI	66.27
Earnings Date	Aug 4, 2025

About Venus Remedies

Venus Remedies Limited engages in the pharmaceutical business in India and internationally. The company offers its products in various therapeutic areas, such as analgesic, analgesic and antipyretic, anti-diabetic, antibiotic, antiemetic, antiviral, cardiovascular, disinfectant and antiseptic, gastro therapy, hepatoprotective, hormones, immunostimulating agent, iron supplements, muscle relaxant, neurology, oncology, solvent, respiratory, and anticoagulant. It is also involved in the provision of portfolio of herbal products. Venus Remedies Limi...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1989
• Employees: 1,187
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: VENUSREM

Financial Performance

In 2024, Venus Remedies's revenue was 6.48 billion, an increase of 7.72% compared to the previous year's 6.01 billion. Earnings were 453.20 million, an increase of 59.07%.